Ludwig Enterprises, Inc. (LUDG)

Market Cap	1.67M -87.6%
Revenue (ttm)	n/a
Net Income	-1.48M
EPS	-0.01
Shares Out	167.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,000
Open	0.0100
Previous Close	0.0100
Day's Range	0.0100 - 0.0121
52-Week Range	0.0100 - 0.0874
Beta	1.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Ludwig Enterprises

Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecula...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1988
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: LUDG

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error